|
Vetoryl®: The reference in the treatment of Cushing's syndrome
Cushing's syndrome (hyperadrenocorticism) ravages the dog's appearance and quality of life. An innovative molecule designed to treat this condition is now available in Canada. Vetoryl® (trilostane) is the first and only approved veterinary medical treatment that addresses both pituitary and adrenal hyperadrenocorticism in dogs. Vetoryl® reduces cortisol levels leading to resolution of clinical signs. In just three months, most clinical signs associated with Cushing's syndrome will be visibly improved with Vetoryl®.
Vetoryl® capsules are available is three convenient sizes (10 mg, 30 mg, 60 mg) to allow flexible and accurate dosing.
Choose Vetoryl®.
Because seeing is believing.
Visit www.vetoryl.ca and you could earn two hours of continuing education credit.
|
